Business Context and Reporting Period
This Form 8-K was filed by Trovagene, Inc. on September 18, 2018. The report discloses an "Other Event" (Item 8.01) regarding the company's scheduled participation as a presenting company at The MicroCap Conference, held on October 1 and 2, 2018, in New York City.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing solely announces the upcoming conference presentation.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the conference appearance. The filing does not provide specific financial guidance, outlook, risk factors, contingencies, or details on unusual items beyond the event disclosure.
Investor Verification Checklist
- Verify the company name: The filing is for Trovagene, Inc., not Cardiff Oncology, Inc. as indicated in the request metadata.
- Confirm the conference details: The MicroCap Conference is scheduled for October 1-2, 2018, at the Essex House in New York City.
- Review the press release: The full details of the announcement are contained in Exhibit 99.1 attached to this filing.
- Check for financial updates: This 8-K contains no financial data; refer to the most recent 10-Q or 10-K for financial metrics.